CVR 28114435Private limited company (ApS)Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749090)Secondary industries: Forskning og eksperimentel udvikling indenfor bioteknologi (721100)Rågevej 12, 2900 HellerupFounded 23 Sep 2004
Compare withsimilar companiesanother companyits industry
BKG HOLDING ApS
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: BKG HOLDING ApS, https://dandex.ai/company/28114435/bkg-holding. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about BKG HOLDING ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
0
CVR, 2018
Gross profit
780.5K
DKK, annual report 2017
Result
+2.4M
DKK, annual report 2017
Equity
-2M
DKK, annual report 2017
BKG 2014 ApSCVR 36060867, 100% of capital and votes, until 2 Jul 2018
Birgit Kjældgaarduntil 17 Jan 2019
No current owner is registered.
15% to under 20% of capital, 66.7% to under 90% of votes15 Dec 2015 to 15 Dec 2017
CVR 2951424020% to under 25% of capital and votesnotified 11 Jun 201831 Dec 2012 to 15 Dec 2017
CVR 36060867100% of capital and votesnotified 11 Jun 20185 Aug 2014 to 2 Jul 2018
BKG HOLDING ApS holds no Danish company now.
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 27959350100% of capital and votes31 Dec 2012 to 27 Dec 2017
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Q4 2018, quarterly: 0 employees, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Q4 2018 |
|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 0 |
| FTE | 1 | 1 | 1 | 1 | 1 | 0 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Quarterly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Q4 2018, published 26 Jun 2019.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2017, DKK: Gross profit 780.5K, Operating profit 2.5M, Result for the year 2.4M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2017, DKK: Total assets 718.1K, Equity -2M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|
| Gross profit | -23 | -23 | -24 | -1,092 | 780 |
| Operating profit | -23 | -23 | -24 | -1,092 | +2,457 |
| Result for the year | -91 | -73 | -75 | -14,117 | +2,415 |
| Equity | 10,442 | 10,369 | 11,276 | -2,784 | -1,984 |
| Total assets | 12,397 | 12,426 | 13,653 | 2 | 718 |
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 347,174, cash price 56.57, implied value 10,395,923 | 56.57 | 347,174 | 10,395,923 | 183,769 | |
| IncreaseCash, debt conversionPaid in 10,291,817, cash price 214.27, implied value 38,061,209 | 214.27 | 10,291,817 | 38,061,209 | 177,632 | |
| FoundingNot read from the announcement | None | None | None | 129,600 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|
| EBITDA | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | 4,133 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | 324note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Merger (fusion), as the continuing company (fortsættende selskab)
Merger (fusion), as the continuing company (fortsættende selskab)
Source: CVR, read 22 Nov 2026.
13 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Binavne:
BKG-Pharma ApS UNDER KONKURS
BKG 2014 ApS UNDER KONKURS
Konkursbehandlingen afsluttet 25.08.2020, virksomheden opløst
Binavne:
BKG-Pharma ApS UNDER TVANGSOPLØSNING
BKG 2014 ApS UNDER TVANGSOPLØSNING
Konkursdekret afsagt 03.07.2019 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Michael Christian Torben Serring, den 03.07.2019.
Revision:
Binavne:
BKG-Pharma ApS UNDER TVANGSOPLØSNING
BKG 2014 ApS UNDER TVANGSOPLØSNING
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Michael Christian Torben Serring, 2100 København Ø, den 20.02.2019.
Virksomheden tegnes af en likvidator.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 17.01.2019
Direktion:
Fratrådte:
Birgit Giwercman, den 17.01.2019.
Revision:
Fratrådte:
PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 17.01.2019.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 36060867 BKG 2014 ApS, der samtidigt er opløst.
Vedtægter ændret: 03.07.2018
Nyt binavn: BKG 2014 ApS
Ny adresse: c/o Birgit Kjældgaard Giwercman, Rågevej 12, 2900 Hellerup
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 28114435 BKG HOLDING ApS (fortsættende), der tillige driver virksomhed under navnene BKG-Pharma ApS og CVR-nummer: 36060867 BKG 2014 ApS (ophørende).
Kapitalejerne i CVR-nummer: 28114435 BKG HOLDING ApS og CVR-nummer: 36060867 BKG 2014 ApS har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 27959350 BKG-PHARMA ApS, der samtidigt er opløst.
Vedtægter ændret: 27.12.2017
Nyt binavn: BKG-Pharma ApS
Formål ændret: Selskabets formål er at være holdingselskab samt investering, handel og dermed beslægtet virksomhed efter direktionens skøn.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 28114435 BKG HOLDING ApS (fortsættende) og CVR-nummer: 27959350 BKG-PHARMA ApS (ophørende).
Kapitalejerne i CVR-nummer: 28114435 BKG HOLDING ApS og CVR-nummer: 27959350 BKG-PHARMA ApS har i enighed besluttet, at der ikke skal udarbejdes en erklæring om kreditorernes stilling i forbindelse med fusionen. Kreditorer, hvis fordringer er stiftet forud for bekendtgørelsen om fusionen, og for hvilke der ikke er stillet særskilt sikkerhed, kan anmelde deres fordringer senest 4 uger efter denne offentliggørelse.
Ny adresse: c/o Birgit Kjældgaard Giwercman, Dyrehavevej 53B, 2930 Klampenborg
Vedtægter ændret:
31.12.2012.
Kapitalforhøjelse:
kr. 6.137,00 indbetalt kontant, kurs 5.657,06.
Kapitalen udgør herefter kr. 183.769,00.
Vedtægter ændret:
10.04.2006.
Kapitalforhøjelse kr. 48.032,00: kr. 47.087,00 indbetalt kontant, kurs 21.427,00, kr. 945,00 indbetalt ved konvertering af gæld, kurs 21.427,00.
Kapitalen udgør herefter kr. 177.632,00.
Stiftelsesdato:
23.09.2004.
Seneste vedtægtsdato:
23.09.2004.
Kapital:
kr. 129.600,00.
Indbetalingsmåde:
i værdier kr. 129.600,00 til kurs 100,00.
Stifter:
Birgit Giwercman, 2920 Charlottenlund, den 23.09.2004.
Direktion:
Birgit Giwercman, 2920 Charlottenlund, den 23.09.2004.
Selskabet tegnes af Selskabet tegnes af en direktør alene. Prokura kan meddeles af direktionen.
Revision:
CVR-NR. 14119299 MUNKEBO, JENSEN & PENSBO STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, postboks 135, 2600 Glostrup, den 23.09.2004.
Første regnskabsår:
23.09.2004 - 31.12.2005.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for BKG HOLDING ApS:
Have Pro? Sign in.
P-number 1010784332Rågevej 12, 2900 Hellerup